WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development

SHANGHAI, Jan. 30, 2024 /PRNewswire/ — WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, announced today that they have reached a comprehensive partnership in drug-linker technology, which … Read more

Results of the Phase III INSPIRE Study on Qilu Pharmaceutical’s Iruplinalkib Published in the Journal of Thoracic Oncology

JINAN, China, Jan. 30, 2024 /PRNewswire/ — The interim analysis results from the phase III INSPIRE study of iruplinalkib developed by Qilu Pharmaceutical, which focuses on the first-line treatment of locally advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), have recently been featured in the Journal of Thoracic Oncology (Impact Factor=20.4), the … Read more

Dr. David Little and Dr. John Flucke Join CandidPro’s World-class Faculty

COLUMBUS, Ohio, Jan. 29, 2024 /PRNewswire/ — Candid, the company behind the revolutionary CandidPro clear aligner system, is opening 2024 with two more significant additions to its already impressive Candid Academy Faculty. David Little, DDS, and John Flucke, DDS, have agreed to bring their expertise and support to CandidPro. With these two industry powerhouses on board, … Read more

E-health Sector Soars with 100% Turnover Growth

DUBAI, UAE, Jan. 28, 2024 /PRNewswire/ — Estonia, renowned for its cutting-edge healthcare research and development, is set to make a significant mark at Arab Health 2024, showcasing its expertise and collaboration opportunities to the GCC region. Estonia’s Digital Health Triumph Shines at Arab Health 2024: E-health Sector Soars with 100% Turnover Growth (PRNewsfoto/Enterprise Estonia) … Read more

Avoid the Low-Volume Thyroid Surgeon

TAMPA, Fla., Jan. 27, 2024 /PRNewswire/ — Thyroid Disease Awareness Month (January) is a pivotal time for raising awareness about the pros and cons of thyroid surgery—one of the most common operations performed in the US. Unfortunately, about 20% of patients having a thyroid operation have something go wrong, resulting in a less than desirable … Read more

AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc.

NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of  Ambrx Biopharma, Inc. (NasdaqGS: AMAM) to Johnson & Johnson (NYSE: JNJ).  Under the terms of the proposed transaction, shareholders of Ambrx … Read more

Critical Path Institute ernennt Dr. Klaus Romero zum neuen CEO und befördert Cécile Ollivier zur Vizepräsidentin für globale Angelegenheiten

AMSTERDAM, 26. Januar 2024 /PRNewswire/ — Das Critical Path Institute (C-Path) hat Dr. Klaus Romero, M.D., M.S., FCP, zu seinem neuen geschäftsführenden Direktor ernannt und Cécile Ollivier, M.S., von Managing-Direktorin, Europa, zur Vizepräsidentin für globale Angelegenheiten befördert. Klaus Romero, M.D., M.S., FCP, Chief Executive Officer, Critical Path Institute Cécile Ollivier, M.S., Vice President of Global … Read more

New Research Hubs Established in the Greater Boston area in the US and Japan to Strengthen Support for Drug Discovery and Innovation

MELVILLE, N.Y., Jan. 25, 2024 /PRNewswire/ — Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide research and development functions as well as drug discovery support development services. Similarly, the Nikon Healthcare R&D Center, a new research and development facility specializing … Read more

Laparoscopic Gynecological Procedures Market Set to Reach $42.3 Billion by 2030 with Robust Technological Innovations and Increasing Demand in Minimally Invasive Surgeries

DUBLIN, Jan. 24, 2024 /PRNewswire/ — The “Global Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report by Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy), End-use (ASCs, Hospitals), Region, and Segment Forecasts, 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. The latest insights on the global laparoscopic gynecological procedures market highlight a projected exponential growth, expecting to achieve … Read more

INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness

Global landscape analysis identifies strengths and gaps in R&D pipeline to inform international pandemic preparedness efforts ROME and CAMBRIDGE, Mass., Jan. 23, 2024 /PRNewswire/ — The INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating the development of antiviral treatments to help protect the world ahead of future pandemics, today published the first phase … Read more